With over twenty years of clinical history, PEEK-OPTIMATM Natural polymer is the first medical-grade PEEK used in spinal fusion surgeries. PEEK is currently the most widely used biomaterial for interbody fusion, accounting for 62% of all devices used in 2018.1 Clinical studies suggest that PEEK-OPTIMATM performs as well as, or better than, interbody fusion devices made of metals or bone, while providing some distinct clinical advantages over competing biomaterials including:

  • Modulus similar to bone
  • Reduced stress shielding
  • Artifact-free imaging

Invibio continues to revolutionize the spinal fusion market with the introduction of PEEK-OPTIMATM HA Enhanced. Hydroxyapatite (HA), a well-known osteoconductive material that enhances bone apposition, is fully integrated, not coated, into the PEEK-OPTIMATM matrix, making it available on all surfaces of a finished device. While offering all of the benefits of PEEK-OPTIMATM Natural, pre-clinical studies have demonstrated potential performance advantages when comparing PEEK-OPTIMA HA Enhanced against PEEK-OPTIMA Natural including:

  • Earlier bone ongrowth with >75% direct bone contact after 4 weeks2
  • Enhanced bone apposition at 12 weeks2
  • Greater new bone formation at 6 weeks3
  • Higher quality new bone bridging at 6 and 12 weeks3
  • Bone ongrowth on the endplates and all faces of the interbody device3
  • Superior mechanical performance outperforming allograft in 46% of the instances3

Early clinical results for cervical and lumbar spinal fusion indicate potential benefits and reveal specific improvements as observed by surgeons4:

  • Solid fusions as early as 6 months
  • Dense bone apposition at the bone-implant interface
  • Positive clinical outcomes at early time points
  • Improvements in overall pain and neurological function


  1. IQVIA, Spinemarket Inc. 2018, Minneapolis, MN.
  2. Study evaluated the bone ongrowth of PEEK-OPTIMATM Natural and PEEK-OPTIMATM HA Enhanced in a bone defect model in sheep. Data on file at Invibio. This has not been correlated with human clinical data.
  3. Study evaluated the in vivo response to PEEK-OPTIMATM Natural, PEEK-OPTIMATM HA Enhanced and allograft in a cervical spine fusion model in sheep. Data on file at Invibio. This data has not been correlated with human clinical experience.
  4. Webinar: PEEK-OPTIMA™ HA Enhanced Devices for Cervical and Lumbar Fusion: Insights from Early Clinical Experience, presented by Timothy Bassett, MD and Brad Prybis, MD, March 2, 2017.

Learn about other Spinal Applications

Explore how our proven PEEK-OPTIMA Polymers can offer potential clinical advantages

Receive the latest clinical evidence and data for PEEK-OPTIMA based applications

By completing this form you are signing up for marketing updates. You will receive targeted messages such as newsletters, tradeshow, webinar and event announcements from Invibio, a member of the Victrex Group or on our behalf. You can unsubscribe at any time. Visit our Privacy Policy to learn more.
The materials on this site are intended for Health Care Professionals and industry users only. If you are a patient, click here, otherwise, click continue.